NEW CRYSTALLINE POLYMORPHIC FORMS OF HEMINAPADHYSILATE 5- (2 - {6- (2,2-DIFFOR-2-PHENYLETOXI) HEXIL AMINO} -1- (R) -HYDROXIETHYL) -8-HYDROXYCHINOHLON-NY-HON-3- (R) -HYDROXYETHYL)) -1- (R) -HYDROXYETHYL)) -1- (R) -HYDROXYETHYLY The quality of β-adrenergic receptor agonists

摘要

The application describes new crystalline polymorphic forms of the heminapadisylate 5- (2 - {[6- (2,2-difluoro-2-phenylethoxy) hexyl] amino} -1- (R) -hydroxyethyl) -8-hydroxyquinoline-2 (1H) -she. The application also describes pharmaceutical compositions containing these crystalline polymorphic forms, methods for their use in the treatment of respiratory diseases associated with β2 adrenergic receptor activity, and a method for producing such crystalline polymorphic.